These substrates when released into the portal vein would enter the liver and activate VAP-1, modulating the expression of adhesion molecules on the hepatic endothelium.5 Thus, our data put forward a novel pathway through which colonic inflammation and amine release may lead to liver damage, providing further links between IBD and PSC. This evidence concerns the gene AOC3 and colitis.